ACTRN12619000160134招募中未知
Retrospective validation of a risk stratification tool developed for management of patients with blunt chest trauma.
Saptarshi Mukerji0 个研究点目标入组 500 人开始时间: 2019年2月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Male or Female, aged 18 years or above. No upper age limit has been set.
- •Patients who have presented with a primary diagnosis of blunt chest trauma.
排除标准
- •Patients with penetrating chest trauma
- •Patients presenting with any immediate life-threatening injuries
- •Patients with multi-trauma defined as any concurrent injuries, in addition to chest trauma, that will significantly determine the patient’s management
研究者
相似试验
已完成
不适用
Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancerColon CancerJPRN-UMIN000023879ational Defense Medical College and Kyushu University1,000
已完成
2 期
Risk Stratification Procedure for Thromboembolism ProphylaxisTotal Knee Replacement SurgeriesNCT04031859Ministry of Health, Saudi Arabia242
已完成
不适用
Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatioSTEMIContrast-induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score,contrast-induced nephropathy,TCTR20190705001/A217
招募中
不适用
Prediction of cancer-associated venous thromboembolismCancer-associated venous thromboembolismNL-OMON23071Amsterdam UMC2,000
已完成
不适用
Risk model to predict adverse outcomes after primary percutaneous coronary intervention (PCI)Acute myocardial infarctionISRCTN83474650Clinical Center of Serbia (Serbia)1,750